Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
ALVAC
Description:
A highly attenuated canarypox virus engineered as a vaccine vector for delivering antigens in infectious disease and cancer research.
Primary topic:
HIV Research and Treatment (47%)
Related topics:
HIV Research and Treatment (47%),
Immunotherapy and Immune Responses (21%),
Poxvirus research and outbreaks (10%)
OpenAlex ID:
keywords/alvac
Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses
1997
·
James W. Hodge
, Joanne P. McLaughlin
, et al.
·
Vaccine
·
205
Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV‐1Mngp120, HIV‐1SF2Recombinant gp120, or Both Vaccines in Seronegative Adults
1998
·
Mary Lou Clements‐Mann
, Kent Weinhold
, et al.
·
The Journal of Infectious Diseases
·
199
Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge
2004
·
J. M. Minke
, L. Siger
, et al.
·
Springer eBooks
·
155
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
2017
·
Todd Bradley
, Justin Pollara
, et al.
·
Nature Communications
·
150
PDF
Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
2001
·
E Kass
, D L Panicali
, et al.
·
PubMed
·
128
Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection
1997
·
C B Stephensen
, J Welter
, et al.
·
Journal of Virology
·
118
Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device
2001
·
João Carlos Aguiar
, Richard C. Hedstrom
, et al.
·
Vaccine
·
114
Canarypox Virus-Induced Maturation of Dendritic Cells Is Mediated by Apoptotic Cell Death and Tumor Necrosis Factor Alpha Secretion
2000
·
Ralf Ignatius
, Mary Marovich
, et al.
·
Journal of Virology
·
112
Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases
1995
·
Marion E Perkvs
, James Tartaglia
, et al.
·
Journal of Leukocyte Biology
·
103
Development and registration of recombinant veterinary vaccines
2006
·
Hervé Poulet
, Jules Minke
, et al.
·
Vaccine
·
99
Enhancing poxvirus vectors vaccine immunogenicity
2014
·
Juan García-Arriaza
, Mariano Esteban
·
Human Vaccines & Immunotherapeutics
·
98
PDF
Induction of Cytotoxic T Lymphocytes by Recombinant Canarypox (ALVAC) and Attenuated Vaccinia (NYVAC) Viruses Expressing the HIV-1 Envelope Glycoprotein
1993
·
William I. Cox
, James Tartaglia
, et al.
·
Virology
·
97
Poxvirus vectors as HIV/AIDS vaccines in humans
2012
·
Carmen Elena Gómez
, Beatriz Perdiguero
, et al.
·
Human Vaccines & Immunotherapeutics
·
90
PDF
Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2)
2003
·
T-M Jourdier
, C Moste
, et al.
·
Gene Therapy
·
89
Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (alvac) cytokine gene delivery induces destruction of established prostate tumors
2001
·
Bennett D. Elzey
, D. Robert Siemens
, et al.
·
International Journal of Cancer
·
78
PDF
The Canarypox Virus Vector ALVAC Induces Distinct Cytokine Responses Compared to the Vaccinia Virus-Based Vectors MVA and NYVAC in Rhesus Monkeys
2013
·
Jeffrey E. Teigler
, Sanjay Phogat
, et al.
·
Journal of Virology
·
76
PDF
Novel Protein and Poxvirus-Based Vaccine Combinations for Simultaneous Induction of Humoral and Cell-Mediated Immunity
2005
·
Claire L Hutchings
, Sarah C Gilbert
, et al.
·
The Journal of Immunology
·
74
PDF
Induction of Neutralizing Antibodies and Gag-Specific Cellular Immune Responses to an R5 Primary Isolate of Human Immunodeficiency Virus Type 1 in Rhesus Macaques
2001
·
David C. Montefiori
, Jeffrey T. Safrit
, et al.
·
Journal of Virology
·
69
Preclinical evaluation of an ALVAC (canarypox)-human cytomegalovirus glycoprotein B vaccine candidate
1995
·
E GONCZOL
, K Berensci
, et al.
·
Vaccine
·
69
Cross-Presentation by Dendritic Cells of Tumor Antigen Expressed in Apoptotic Recombinant Canarypox Virus-Infected Dendritic Cells
2001
·
Iris Motta
, Fabrice André
, et al.
·
The Journal of Immunology
·
68
PDF
Highly Attenuated HIV Type 2 Recombinant Poxviruses, but Not HIV-2 Recombinant Salmonella Vaccines, Induce Long-Lasting Protection in Rhesus Macaques
1995
·
GENOVEFFA FRANCHINI
, MARJORIE ROBERT-GUROFF
, et al.
·
AIDS Research and Human Retroviruses
·
65
Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination
2006
·
J.M. Minke
, L. Fischer
, et al.
·
Veterinary Immunology and Immunopathology
·
63
Effect of Canarypox Virus (ALVAC)-Mediated Cytokine Expression on Murine Prostate Tumor Growth
1997
·
M. Kawakita
, G. S. Rao
, et al.
·
JNCI Journal of the National Cancer Institute
·
63
Canarypox Virus-Mediated Interleukin 12 Gene Transfer into Murine Mammary Adenocarcinoma Induces Tumor Suppression and Long-Term Antitumoral Immunity
1998
·
Isabelle Puisieux
, Laurence Odin
, et al.
·
Human Gene Therapy
·
61
CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals
2008
·
Jun Liu
, Qigui Yu
, et al.
·
Vaccine
·
60
Show more works
View as search
Works count:
114
Citation count:
3,879
Year
Topic
Type